New study finds fewer drugs covered by USA’s Medicare

13 October 2014

An analysis of US government data on 2015 Medicare drug plans by HealthPocket has found that the average number of covered drugs has decreased compared to 2014 but the incidence of restrictions placed on covered drugs has increased.

At an average of 1,485 drugs, Medicare Advantage plans in 2015 covered 5% more drugs than the average for 2015 Medicare Part D plans.

Given the number of covered drugs, the percentage of drugs with restrictions represents hundreds of on-formulary medications for the average Medicare drug plan. An average of 34% of covered drugs in Medicare Advantage plans have restrictions placed on the coverage. For Medicare Part D plans, the level of drug restrictions is even higher at 37%.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical